M D Caballero

Author PubWeight™ 44.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol 2005 1.88
2 High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma. Br J Haematol 1999 1.84
3 Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group. J Clin Oncol 2001 1.43
4 Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS. Bone Marrow Transplant 1999 1.41
5 High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience. Ann Oncol 2003 1.20
6 Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens. Bone Marrow Transplant 2001 1.10
7 The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol 2007 1.10
8 Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial. Bone Marrow Transplant 2004 1.04
9 Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study. Bone Marrow Transplant 2004 1.04
10 Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. Br J Haematol 2001 0.99
11 Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia. J Clin Oncol 1998 0.96
12 Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease. Br J Haematol 2001 0.91
13 Iron metabolism and fungal infections in patients with haematological malignancies. J Clin Pathol 1995 0.90
14 Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001 0.89
15 Hematopoietic SCT for peripheral T-cell lymphoma. Bone Marrow Transplant 2008 0.89
16 Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience. Ann Oncol 2004 0.87
17 p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies. Hematol J 2001 0.86
18 Characterization of aberrant phenotypes in acute myeloblastic leukemia. Ann Hematol 1995 0.85
19 A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique. Cytometry 1994 0.84
20 Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant. Bone Marrow Transplant 2002 0.84
21 Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation. Haematologica 2001 0.84
22 Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome. Ann Oncol 2003 0.84
23 How can we improve problem solving in undergraduate biology? Applying lessons from 30 years of physics education research. CBE Life Sci Educ 2013 0.83
24 Rhabdomyolysis associated with septicemia after autologous bone marrow transplantation. Bone Marrow Transplant 1997 0.82
25 Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry. Leuk Lymphoma 1994 0.82
26 Pathologic rupture of the spleen during induction with ATRA in a patient with acute promyelocytic leukemia. Med Oncol 2000 0.82
27 CD34 + cell dose and outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation. Leuk Lymphoma 2005 0.82
28 Relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation. Eur J Haematol 1996 0.82
29 Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001 0.81
30 Immune thrombocytopenic purpura secondary to endometriosis. Haematologica 1998 0.81
31 Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia. Leukemia 1993 0.81
32 Identification of factors associated with poor peripheral blood progenitor cell mobilization in Hodgkin's disease. Haematologica 2001 0.80
33 Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics. Blood 1988 0.79
34 Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease. Br J Cancer 1993 0.79
35 Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantation. Ann Oncol 2010 0.79
36 The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Leukemia 2000 0.78
37 Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs. Bone Marrow Transplant 2010 0.78
38 Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion 1998 0.78
39 T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia. Am J Hematol 1985 0.78
40 T cells subpopulations in untreated and treated patients with haemophilia A and B. Blut 1983 0.78
41 Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation. Bone Marrow Transplant 2006 0.78
42 Immunological phenotype of neoplasms involving the B cell in the last step of differentiation. Br J Haematol 1986 0.77
43 Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery. Haematologica 1999 0.77
44 Phenotypic characterization of skin-infiltrating cells in pagetoid reticulosis by monoclonal antibodies. Acta Derm Venereol 1984 0.77
45 [Immune reconstitution after autologous progenitor hemopoietic cell transplantation. A study comparing autologous bone marrow and autologous peripheral blood transplantation]. Med Clin (Barc) 1998 0.76
46 Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms. Bone Marrow Transplant 2010 0.76
47 Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation. Bone Marrow Transplant 2000 0.76
48 Factors that influence long-term hematopoietic function following autologous stem cell transplantation. Bone Marrow Transplant 1999 0.76
49 Value of colony forming unit-granulocyte macrophage assay in predicting relapse in acute myeloid leukaemia. J Clin Pathol 1996 0.75
50 Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study. Bone Marrow Transplant 2004 0.75
51 Peculiar cytogenetic finding in T-cell lymphoproliferative disorders. Cancer Genet Cytogenet 1985 0.75
52 [Immunologic characterization of hairy-cell leukemia or tricholeukemia]. Sangre (Barc) 1984 0.75
53 [Guillain-Barr+e syndrome after autologous bone marrow transplantation]. Sangre (Barc) 1998 0.75
54 [Immunologic and enzymatic markers of acute infantile lymphoblastic leukemias]. An Esp Pediatr 1984 0.75
55 [Controversies in the determination of CD34]. Sangre (Barc) 1997 0.75
56 [Immunologic phenotypes of acute lymphoblastic leukemias and their clinico-biological correlations]. Sangre (Barc) 1984 0.75
57 [Invasive aspergillosis in patients with malignant hemopathies. Usefulness of direct and serologic diagnosis]. Sangre (Barc) 1993 0.75
58 Clinical and immunological findings in large B-cell chronic lymphocytic leukemia. Clin Immunol Immunopathol 1988 0.75
59 [Results of a series of 104 consecutive bilateral bone marrow biopsy specimens in lymphoproliferative disorders]. Sangre (Barc) 1995 0.75
60 Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease. Neoplasma 1985 0.75
61 Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma. Bone Marrow Transplant 2004 0.75
62 [Influence of hematopoietic growth factors on transfusion support following autologous bone marrow transplantation]. Sangre (Barc) 1995 0.75
63 [Monoclonal gammopathies. Progress in differential diagnosis based on immunologic markers]. Sangre (Barc) 1984 0.75
64 A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation. Br J Haematol 1996 0.75
65 An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia. Cytometry 1999 0.75
66 [The megakaryoblastic component of mixed blast crises]. Sangre (Barc) 1985 0.75
67 Bone marrow histopathologic patterns and immunologic phenotype in B-cell chronic lymphocytic leukaemia. Blut 1988 0.75
68 Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients. Hematol Cell Ther 1997 0.75
69 [Lymphocyte populations in hemophilia A and B. Relation to acquired immunodeficiency syndrome and therapeutic implications]. Sangre (Barc) 1983 0.75
70 [Cytochemistry of tricholeukemia]. Sangre (Barc) 1983 0.75
71 [Immunologic phenotype of chronic T lymphatic leukemia]. Med Clin (Barc) 1984 0.75
72 Complete cytogenetic but not molecular remission in a patient with myeloid blast crisis of chronic myeloid leukemia treated with carboplatin and ara-C. Haematologica 1998 0.75
73 Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: effect of human platelet antigen mismatch on platelet engraftment and graft-versus-host disease. Transfusion 2004 0.75
74 Long-term treatment results for acute megakaryoblastic leukaemia patients: a multicentre study. Br J Haematol 1992 0.75
75 Immunoblastic lymphoma and associated non-lymphoid malignancies following two cases of Waldenström's macroglobulinemia. A review of the literature. Eur J Haematol 1993 0.75
76 Histiocytic cytophagic panniculitis: a rare late complication of allogeneic bone marrow transplantation. Bone Marrow Transplant 1994 0.75
77 [The importance of terminal deoxyribonucleotidyl transferase in myeloblastic leukemias. Apropos of 2 cases]. Sangre (Barc) 1983 0.75
78 Monocyte counts: an early index of haemopoietic reconstitution after peripheral blood stem cell transplantation. Br J Haematol 2000 0.75